LONDON, April 15, 2025 /PRNewswire/ — A unused, mid-size Promise Construction Production Organisation (CDMO), Meribel Pharma Solutions has introduced nowadays with an intensive built-in community throughout Europe, led by way of a workforce of business professionals on a project to bring the best component answers and products and services to allow consumers to scale to unused heights and give a boost to affected person fitness.
The company has ten production websites and 3 drug construction products and services websites, located throughout France, Spain and Sweden, following the purchase of CDMO, Synerlab Staff and 7 Ecu production amenities from Recipharm closing time.
Meribel Pharma Answers is headed up by way of an skilled workforce together with CEO, Bruce Vielle, previously President, CEO of Synerlab, and COO, Steve Leonard, who joins the company from Integra Year Sciences the place he used to be Company VP, World Operations & Provide Chain. Previous to that, he used to be SVP, Head of World Operations at Catalent.
Constructed on a robust legacy of experience in oral strong dose (OSD) production, semi-solid dosage formulations, and sterile drug merchandise, the company has established facilities of excellence in drug construction, lyophilisation, preservative-free multidose applied sciences, and versatile stick-pack and sachet manufacturing. From idea to commercialisation, Meribel Pharma Answers can ship area of interest technical experience at each and every degree of the drug construction proceed.
Running below stringent international regulatory certifications, the corporate helps each human and veterinary fitness merchandise.
Meribel Pharma Answers CEO, Bruce Vielle mentioned: “There is a gap in the market for a niche-player, mid-sized CDMO that’s focused, agile, and dedicated to solving complex challenges, and we are well positioned to fulfill this unmet need.”
“We have invested heavily in the latest technologies and expanded our capacity to meet the evolving needs of our customers. As a unified organisation, our foundations are built on quality and reliability. We bring together greater resources, deeper expertise, and enhanced agility, enabling us to meet our customers’ requirements better than ever before.”
“We’re deeply committed to delivering the highest quality in everything we do. Our regulatory and quality experts work with our clients to help ensure their products exceed the most stringent standards. With certified sites and a shared focus on continuous improvement, we are set up to deliver exceptional results.”
The title Meribel Pharma Answers is encouraged by way of the Meribel mountain territory within the Alps. Situated within the 3 Valleys in France, the title symbolises the company bringing in combination production excellence from throughout 3 nations, France, Spain and Sweden. Additionally it is a nod to the company’s loyalty to serving to consumers navigate advanced demanding situations and succeed in unused heights in drug construction and production.
About Meribel Pharma Answers
Meribel Pharma Answers is a mid-sized CDMO, headquartered in the United Kingdom, and with 13 websites for production and drug construction products and services situated throughout France, Spain and Sweden. The corporate is subsidized by way of Blue Wolf Capital Companions LLC (“Blue Wolf”), a middle-market personal fairness company specialising within the commercial and healthcare sectors.
Offering specialist experience in sterile multidose, lyophilization, sachets and stick packs, and construction products and services, the company helps drug construction from idea thru to commercialisation, along OSD, semi strong dosage production products and services.
Brand – https://mma.prnewswire.com/media/2664024/Meribel_Pharma_Solutions_Logo.jpg
SOURCE Meribel Pharma Answers
